{"id":47445,"date":"2017-07-27T16:47:40","date_gmt":"2017-07-27T20:47:40","guid":{"rendered":"https:\/\/asweetlife.org\/?p=47445"},"modified":"2017-07-27T16:47:40","modified_gmt":"2017-07-27T20:47:40","slug":"jdrf-advocacy-in-the-age-of-trumpcare","status":"publish","type":"post","link":"https:\/\/asweetlife.org\/?p=47445","title":{"rendered":"JDRF Advocacy in the Age of Trumpcare"},"content":{"rendered":"

With Congress due to leave for August recess at the end of this week, those following Republicans\u2019 efforts to replace Obamacare with Trumpcare are expecting one more push. In Monday\u2019s New York Times, <\/em>the opinion columnist Paul Krugman wrote that even though many view Republicans\u2019 efforts to replace health care as dead, this week is a particularly dangerous time, with people distracted by the burgeoning Russia scandal. \u201cMany people I know [are] worried that we may see a repeat of what happened in the spring: with the media spotlight shining elsewhere, the usual suspects may ram a horrible bill through. And the House would quickly pass whatever the Senate comes up with. So this is actually a moment of great risk.\u201d<\/p>\n

A couple of weeks ago, just before the Senate bill seemingly fell apart, I went to a conference called Partnering for Cures (organized by Faster Cures, a center at the Milken Institute)<\/a>, where people from all sides of the medical community\u2014from patients to researchers to biotech, pharmaceutical, and insurance executives to philanthropists to people from the FDA and NIH\u2014come together to work on achieving faster cures for disease. There were a range of panels and roundtables on how to speed up research\u2014including ideas on sharing \u201cscruffy\u201d data among researchers, patients, and centers; and a workshop on making clinical trials more accessible. But underlying all the discussion of medicine and how to improve it is the basic issue that the health care system is shifting under the country\u2019s feet. We don\u2019t know how it will change, but we know it will change.<\/p>\n

So while I was at the conference, I was glad to have the chance to sit down with Cynthia Rice, JDRF\u2019s senior vice president of advocacy and policy, and to hear her speak on a panel about the federal policy landscape. JDRF, as Moira McCarthy wrote about earlier this year<\/a>\u00a0is a powerful presence on Capitol Hill, lobbying for those with type 1 diabetes, and by extension for all those with preexisting conditions. Rice pointed out how hundreds of JDRF advocates have been meeting with their members of Congress, and talking with them about their priorities for health care reform: maintaining the protection of people with preexisting conditions; continuing to allow people to stay on their parents\u2019 health plans until the age of 26; keeping insurance companies from setting annual and\/or lifetime limits for receiving benefits; and closing the \u201cdonut hole\u201d in Medicare coverage (where a prescription drug benefit plan will only cover a certain amount per year, after which patients are fully responsible for costs up until they have reached their mandated yearly limits). Rice pointed out that JDRF is part of a broader coalition of patient organizations who have been meeting with congressmen\u2014both in Washington and in their home states\u2014and lobbying hard against changes in health care that would hurt those with chronic diseases.<\/p>\n

JDRF\u2019s work on health care is part of a robust agenda in Washington, DC, including educating the FDA about technologies like encapsulation and beta cell replacement; pushing companies to use other measures aside from A1C to evaluate T1D outcomes, and pushing for insurance coverage for artificial pancreas technology. In the panel on federal policy, Rice talked about JDRF\u2019s roots as an organization whose goal is to push the federal government to use its muscle, funding and otherwise, to try to cure T1D; and she emphasized the continued importance of the federal government in the search for treatments and cures. \u201cMy organization was founded by parents of children with type one diabetes who wanted a cure for their children. And partnering for cures is an important theme for this disease\u2026. We need the government to play a partnership role with patient organizations, with researchers, and with the private sector,\u201d Rice said. She used the example of the artificial pancreas to show how JDRF works with the federal government over the long term, in a strategic way. She described how getting the FDA to approve the first artificial pancreas system, which happened last year, was part of a long process that started more than a decade ago. \u201cWe want multiple versions of [an automated insulin dosing system] on the market so in 2006 we started working with the FDA to define the pathway to minimize the uncertainty, and that resulted in guidance in 2012 which ultimately resulted in therapy in 2016. So it can take time, but I think you need to look ahead and say, \u2018What\u2019s the uncertainty you\u2019re trying to diminish, and how can we get there?\u2019\u201d<\/p>\n

Another panelist, Robert Califf, a commissioner of the FDA under Obama, commented that in that role he saw how important it was for a given disease to have strong advocacy, as T1D has with JDRF. \u201cIt was painful to me to see diseases where there wasn\u2019t effective advocacy. Let\u2019s face it, if you have effective advocacy, not only are you more likely to get therapies developed, you\u2019re more likely to get them paid for,\u201d he said. But in the current health care landscape Califf was even more worried about disparities of a different kind: the widening disparities in health care outcomes between the rich and the poor\u2014a gap that he believes will only widen if Republicans succeed in passing their health care law. \u201cMy personal view is, if I were teaching a class in how to create disparities, I would say, take that bill, and that is the formula to create the greatest disparities in this country you could imagine\u2026. It is not a good time to be a poor person in America.\u201d But Califf closed his thoughts on the health care bill on a note of restrained optimism, with the opinion that the two parties do have some common ground on health reform\u2014if only they\u2019d be willing to seek it out. \u201cIf the two parties were locked in a room and couldn\u2019t come out until they agreed, I think there\u2019s enough between the two points of view that they could come out with something pretty good. So maybe we should just go down and surround the Capitol.\u201d Even if only metaphorically, surrounding the Capitol is something JDRF has been doing since it was founded, almost fifty years ago. And the need for its passionate advocacy is only increasing.<\/p>\n","protected":false},"excerpt":{"rendered":"

…<\/p>\n","protected":false},"author":18,"featured_media":38334,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1429,1541],"tags":[],"yoast_head":"\nJDRF Advocacy in the Age of Trumpcare | ASweetLife<\/title>\n<meta name=\"description\" content=\"JDRF\u2019s work on health care is part of a robust agenda in Washington, DC, including educating the FDA about technologies like encapsulation and beta cell replacement;\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/asweetlife.org\/?p=47445\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Katie Bacon\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/asweetlife.org\/?p=47445\",\"url\":\"https:\/\/asweetlife.org\/?p=47445\",\"name\":\"JDRF Advocacy in the Age of Trumpcare | ASweetLife\",\"isPartOf\":{\"@id\":\"https:\/\/asweetlife.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/asweetlife.org\/?p=47445#primaryimage\"},\"image\":{\"@id\":\"https:\/\/asweetlife.org\/?p=47445#primaryimage\"},\"thumbnailUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2015\/10\/JDRF-Logo.jpg\",\"datePublished\":\"2017-07-27T20:47:40+00:00\",\"dateModified\":\"2017-07-27T20:47:40+00:00\",\"author\":{\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/d9db494b4a0cbf28744f6c4a9c73329e\"},\"description\":\"JDRF\u2019s work on health care is part of a robust agenda in Washington, DC, including educating the FDA about technologies like encapsulation and beta cell replacement;\",\"breadcrumb\":{\"@id\":\"https:\/\/asweetlife.org\/?p=47445#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/asweetlife.org\/?p=47445\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/?p=47445#primaryimage\",\"url\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2015\/10\/JDRF-Logo.jpg\",\"contentUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2015\/10\/JDRF-Logo.jpg\",\"width\":600,\"height\":400,\"caption\":\"JDRF\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/asweetlife.org\/?p=47445#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/asweetlife.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"JDRF Advocacy in the Age of Trumpcare\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/asweetlife.org\/#website\",\"url\":\"https:\/\/asweetlife.org\/\",\"name\":\"ASweetLife\",\"description\":\"The Diabetes Magazine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/asweetlife.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/d9db494b4a0cbf28744f6c4a9c73329e\",\"name\":\"Katie Bacon\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/8cc124bd5d3d2d03be80239ba09df7cc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/8cc124bd5d3d2d03be80239ba09df7cc?s=96&d=mm&r=g\",\"caption\":\"Katie Bacon\"},\"description\":\"Katie Bacon is a writer and editor based in Boston. Her daughter, Bisi, was diagnosed with type 1 diabetes in August, 2012, when she was six. Katie worked as an editor at The Atlantic, and her writing has appeared in The New York Times, The Boston Globe, and other publications. Katie and her husband, Mark, have two children\u2014Bisi and her older brother, Jamie.\",\"url\":\"https:\/\/asweetlife.org\/?author=18\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"JDRF Advocacy in the Age of Trumpcare | ASweetLife","description":"JDRF\u2019s work on health care is part of a robust agenda in Washington, DC, including educating the FDA about technologies like encapsulation and beta cell replacement;","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/asweetlife.org\/?p=47445","twitter_misc":{"Written by":"Katie Bacon","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/asweetlife.org\/?p=47445","url":"https:\/\/asweetlife.org\/?p=47445","name":"JDRF Advocacy in the Age of Trumpcare | ASweetLife","isPartOf":{"@id":"https:\/\/asweetlife.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/asweetlife.org\/?p=47445#primaryimage"},"image":{"@id":"https:\/\/asweetlife.org\/?p=47445#primaryimage"},"thumbnailUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2015\/10\/JDRF-Logo.jpg","datePublished":"2017-07-27T20:47:40+00:00","dateModified":"2017-07-27T20:47:40+00:00","author":{"@id":"https:\/\/asweetlife.org\/#\/schema\/person\/d9db494b4a0cbf28744f6c4a9c73329e"},"description":"JDRF\u2019s work on health care is part of a robust agenda in Washington, DC, including educating the FDA about technologies like encapsulation and beta cell replacement;","breadcrumb":{"@id":"https:\/\/asweetlife.org\/?p=47445#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/asweetlife.org\/?p=47445"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/?p=47445#primaryimage","url":"https:\/\/asweetlife.org\/wp-content\/uploads\/2015\/10\/JDRF-Logo.jpg","contentUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2015\/10\/JDRF-Logo.jpg","width":600,"height":400,"caption":"JDRF"},{"@type":"BreadcrumbList","@id":"https:\/\/asweetlife.org\/?p=47445#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/asweetlife.org\/"},{"@type":"ListItem","position":2,"name":"JDRF Advocacy in the Age of Trumpcare"}]},{"@type":"WebSite","@id":"https:\/\/asweetlife.org\/#website","url":"https:\/\/asweetlife.org\/","name":"ASweetLife","description":"The Diabetes Magazine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/asweetlife.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/d9db494b4a0cbf28744f6c4a9c73329e","name":"Katie Bacon","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8cc124bd5d3d2d03be80239ba09df7cc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8cc124bd5d3d2d03be80239ba09df7cc?s=96&d=mm&r=g","caption":"Katie Bacon"},"description":"Katie Bacon is a writer and editor based in Boston. Her daughter, Bisi, was diagnosed with type 1 diabetes in August, 2012, when she was six. Katie worked as an editor at The Atlantic, and her writing has appeared in The New York Times, The Boston Globe, and other publications. Katie and her husband, Mark, have two children\u2014Bisi and her older brother, Jamie.","url":"https:\/\/asweetlife.org\/?author=18"}]}},"_links":{"self":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/47445"}],"collection":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=47445"}],"version-history":[{"count":4,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/47445\/revisions"}],"predecessor-version":[{"id":47449,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/47445\/revisions\/47449"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/media\/38334"}],"wp:attachment":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=47445"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=47445"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=47445"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}